We did not observe the same increase in either lymphoma cell lines or LCLs with acquired resistance, and the ratio of the shorter splice variants to the total amount of CD20 (both mRNA and protein) remained constant or decreased. The gene discussed is MS4A1; the disease is lymphoma.